Moderna Stock Doubles on Cancer Breakthrough: Here’s What It Means
A Phase 3 win against the standard of care sent the biotech's shares up 131% and left short sellers down $4.8 billion.
- Source
- Decrypt
- Published
- 2026-08-19 16:54 UTC
- Cache updated
- 2026-08-19 17:01 UTC
This page shows only the title, summary, and source metadata. Read the full story at the original source.
Open original ↗Check transfer feesRelated topics
01Users and Apps02Market and Policy
Decrypt
Follow consumer wallet, application, security, DeFi, and market updates before deciding whether Energy rental is needed.
Crypto Market, Regulation, and Stablecoin Policy News
Track crypto market, regulatory, stablecoin, and major-asset updates for broader blockchain context.